Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01816152 · ClinicalTrials.gov registry record · NA
Methodology Issues in a Tailored Light Treatment for Persons With Dementia
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 45
- Enrollment target
NCT01816152 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 45 participants.
The verdict
NCT01816152, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 45 participants
- Enrollment target
Study Summary
Tailored light treatment will increase sleep efficiency, reduce depression and reduce agitation scores in those with Alzheimer's disease and related dementia
Interventions
- OTHER Tailored Active intervention
- OTHER Inactive intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2020-01-01 |
| Est. Completion | 2024-05-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01816152
The ClinicalTrials.gov registry entry for NCT01816152 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Tailored Active intervention is the first listed.
NCT01816152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01816152 about?
NCT01816152 is a clinical study titled "Methodology Issues in a Tailored Light Treatment for Persons With Dementia". Tailored light treatment will increase sleep efficiency, reduce depression and reduce agitation scores in those with Alzheimer's disease and related dementia
What is the current status of trial NCT01816152?
This trial is currently completed. It is a NA study. The enrollment target is 45 participants. The study started on 2020-01-01. Estimated completion is 2024-05-10.
What interventions are being tested in trial NCT01816152?
The interventions under investigation include: Tailored Active intervention (OTHER), Inactive intervention (OTHER).
Who is sponsoring clinical trial NCT01816152?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.